Endotoxaemia Completed Phase 4 Trials for Defibrotide (DB04932)

Also known as: Endotoxemia / Endotoxemia (disorder)

IndicationStatusPhase
DBCOND0014110 (Endotoxaemia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02876601Defibrotide in the Human Endotoxemia Model --- an Exploratory Trial Investigating the Effects and the Mechanisms of DefibrotideBasic Science